These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3113985)

  • 1. Neurochemical and behavioural evidence for an agonist action of 1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine (LY 165163) at central 5-HT receptors.
    Hutson PH; Donohoe TP; Curzon G
    Eur J Pharmacol; 1987 Jun; 138(2):215-23. PubMed ID: 3113985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blockade of dopamine receptors explains the lack of 5-HT stereotypy on treatment with the putative 5-HT1A agonist LY165163.
    Donohoe TP; Hutson PH; Curzon G
    Psychopharmacology (Berl); 1987; 93(1):82-6. PubMed ID: 2957721
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Central serotonin agonist actions of LY 165163, 1-(m-trifluoromethylphenyl)-4-(p-aminophenylethyl) piperazine, in rats.
    Fuller RW; Snoddy HD; Molloy BB
    J Pharmacol Exp Ther; 1986 Nov; 239(2):454-9. PubMed ID: 2430093
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypothalamic neurochemistry and feeding behavioral responses to clonidine, an alpha-2-agonist, and to trifluoromethylphenylpiperazine, a putative 5-hydroxytryptamine-1B agonist, in genetically obese Zucker rats.
    Koulu M; Huupponen R; Hänninen H; Pesonen U; Rouru J; Seppälä T
    Neuroendocrinology; 1990 Nov; 52(5):503-10. PubMed ID: 1980723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioral and biochemical effects of the 5-HT1A receptor agonists flesinoxan and 8-OH-DPAT in the rat.
    Ahlenius S; Larsson K; Wijkström A
    Eur J Pharmacol; 1991 Aug; 200(2-3):259-66. PubMed ID: 1838333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mixed agonist-antagonist properties of umespirone at neostriatal dopamine receptors in relation to its behavioral effects in the rat.
    Ahlenius S; Wijkström A
    Eur J Pharmacol; 1992 Nov; 222(1):69-74. PubMed ID: 1361441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. (R)- and (S)-8-acetyl-2-(dipropylamino)tetralin (LY-41): two novel 5-HT1A receptor agonists.
    Yu H; Liu Y; Hacksell U; Lewander T
    Eur J Pharmacol; 1993 Jan; 231(1):69-76. PubMed ID: 8444282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is the potent 5-HT1A receptor agonist, alnespirone (S-20499), affecting dopaminergic systems in the rat brain?
    Dugast C; Soulière F; Schmitt P; Casanovas JM; Fattaccini CM; Mocaër E; Lesourd M; Renaud B; Artigas F; Hamon M; Chouvet G
    Eur J Pharmacol; 1998 Jun; 350(2-3):171-80. PubMed ID: 9696405
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Properties of some 1-arylpiperazines as antagonists of stereotyped behaviors mediated by central serotonergic receptors in rodents.
    Simansky KJ; Schechter LE
    J Pharmacol Exp Ther; 1988 Dec; 247(3):1073-81. PubMed ID: 3144595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity.
    Lucki I; Ward HR; Frazer A
    J Pharmacol Exp Ther; 1989 Apr; 249(1):155-64. PubMed ID: 2709329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors.
    Goodwin GM; Green AR
    Br J Pharmacol; 1985 Mar; 84(3):743-53. PubMed ID: 2580582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 1-(1-Naphthyl)piperazine, a central serotonin agonist.
    Fuller RW; Mason NR; Snoddy HD; Perry KW
    Res Commun Chem Pathol Pharmacol; 1986 Jan; 51(1):37-45. PubMed ID: 2419952
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Further investigation of the in vivo pharmacological properties of the putative 5-HT1A antagonist, BMY 7378.
    Sharp T; Backus LI; Hjorth S; Bramwell SR; Grahame-Smith DG
    Eur J Pharmacol; 1990 Feb; 176(3):331-40. PubMed ID: 1970304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonin-lesion myoclonic syndromes. I. Neurochemical profile and S-1 receptor binding.
    Pranzatelli MR; Rubin G; Snodgrass SR
    Brain Res; 1986 Jan; 364(1):57-66. PubMed ID: 3484992
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased 5-hydroxytryptamine turnover in striatum and other brain regions after administration of 5-methoxy-3-(di-n-propylamino)chroman to rats.
    Fuller RW; Perry KW; Ward JS
    J Pharm Pharmacol; 1989 Nov; 41(11):805-6. PubMed ID: 2576058
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5-HT1A autoreceptor-mediated effects of the amperozide congeners, FG5865 and FG5893, on rat brain 5-hydroxytryptamine neurochemistry in vivo.
    Hjorth S; Pettersson G
    Eur J Pharmacol; 1993 Jul; 238(2-3):357-67. PubMed ID: 7691622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of Bay K 8644 on the synthesis and metabolism of dopamine and 5-hydroxytryptamine in various brain areas of the rat.
    Colado MI; Ormazabal MJ; Alfaro MJ; Martin MI
    J Pharm Pharmacol; 1993 Mar; 45(3):220-2. PubMed ID: 7683338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonin agonist actions of p-chlorophenylalanine.
    Sloviter RS; Drust EG; Connor JD
    Neuropharmacology; 1978 Dec; 17(12):1029-33. PubMed ID: 154622
    [No Abstract]   [Full Text] [Related]  

  • 20. Receptor reserve for 5-hydroxytryptamine1A-mediated inhibition of serotonin synthesis: possible relationship to anxiolytic properties of 5-hydroxytryptamine1A agonists.
    Meller E; Goldstein M; Bohmaker K
    Mol Pharmacol; 1990 Feb; 37(2):231-7. PubMed ID: 1968223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.